Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Simon-Kucher on a Steady Growth Path

The management consultancy, which has seven US offices, continues to grow despite the difficult economic year. New partners strengthen the company’s expertise, particularly in the Life Sciences division. In addition, the consultancy is planning to establish its own software venture.[Boston, MA], [Jan. 27, 2021] – The global strategy and marketing consultancy Simon-Kucher & Partners  ended the 2020 financial year with an annual revenue of 406.2 million US dollars. This equals a growth rate of one percent compared to the previous year, with the Life Sciences

Q-Free: Acceptances received under mandatory offer to acquire all shares in Q-Free ASA

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of holders in, any jurisdiction in which the making of the Offer, the distribution of this stock exchange announcement or the acceptance of any tender of shares would contravene applicable laws or regulations. (Oslo, 27 January 2021): Reference is made to the mandatory offer (the “Offer”) from Rieber & Søn AS (the “Offeror”) to acquire all shares in Q-Free ASA (“Q-Free” or the “Company”) pursuant to an offer document

Per Bertland to step down as CEO of Beijer Ref during 2021

Per Bertland has today informed Beijer Ref’ AB:s (publ) Board of Directors that he plans to step down as CEO. The transition will take place when a successor has been found or during the latter part of 2021 at the latest. Per intends to remain active within Beijer Ref by making himself available to join the Board of Directors, if supported by the shareholders. Beijer Ref’s largest shareholder, EQT Private Equity, has expressed its intention to call for a general meeting whereby they will nominate Per as a member of the Board of Directors. Bernt Ingman, Chairman of the Board of Directors,

Alligator Bioscience’s rights issue oversubscribed

Alligator Bioscience AB (publ) (“Alligator” or the “Company”) has completed the share issue with pre-emption rights for the Company’s shareholders, which was resolved upon by the Board of Directors on December 15, 2020 pursuant to the authorization from the annual general meeting on May 5, 2020 (the “Rights Issue”). The subscription period ran from and including January 11, 2021 to and including January 25, 2021. Through the Rights Issue, Alligator receives approximately SEK 86 million before deduction of issue costs. 13 895 925 shares, corresponding to approximately 97 per cent of the Rights

Submission deadline of the E1|R1 Photo Award extended until mid-March

Third edition of the amateur photo competition along the E1 and R1 long-distance trails calls on Europe's hikers and cyclists to send in their entriesThe third edition of the E1|R1 Photo Award, organized by Lippe Tourismus und Marketing GmbH (LTM), Detmold, has been running since October 15. Even under difficult corona conditions, the European hiking and photo community shows what it is made of with strong motifs from all over Europe. Nevertheless, the competition is also feeling the effects of the ongoing Corona pandemic. "In demand this particular year are the national hikers and cyclists

Surgical Science completes the acquisition of Mimic Technologies

Surgical Science Sweden AB (publ) announced on January 20, 2021 that a conditional agreement to acquire all shares outstanding of Mimic Technologies Inc. (“Mimic”) with operations within the robotic surgery segment had been entered into. Mimic is based in Seattle, USA and through the acquisition Surgical Science further expands its customer base within the robotic surgery segment, gains access to technology for data collection/advanced analytics and strengthens its footprint in the highly important American market. Surgical Science Sweden AB (publ) today, after all conditions precedent

Communiqué from the Extraordinary General Meeting of BoMill AB (publ)

In accordance with the Board of Directors’ proposal, the Extraordinary General Meeting in BoMill AB (publ) on January 27, 2021 resolved on a directed issue of 330,000 warrants, whereupon the company’s share capital may be increased by maximum SEK 330,000.The warrants shall entitle rights for officers of the company, founder and Member of the Board Bo Löfqvist (205 000 warrants) and Managing Director Andreas Jeppsson (125 000 warrants), to subscribe for new shares in the company according to the following.  The warrants will be issued against payment where the subscription price shall be

Result update Q4, full year 2020 and the board of directors’ dividend proposal - Regulatory information

Preliminary numbers indicate very strong growth for ADDvise Group during the fourth quarter for 2020, which will be substantially better than last year. ADDvise Group considers this to be above market expectations. With a more normalized market, an increase of ADDvise’s own products and margins, and a continued control of costs; EBITDA has increased as a result in the fourth quarter 2020. The net sales and EBITDA result 2020 will be ADDvise Group’s strongest so far. · The EBITDA result of the fourth quarter 2020 is estimated to approximately SEK 15.9 million (9.6), corresponding to an

Attana has published the company presentation given on Biotech Showcase™ 2021

The conference this year took place in digital form between January 11 to January 15. During the conference Attana broadcasted a 25-minute presentation, which is now published on Attana’s website and Youtube channel. In addition to the presentation, Attana had several rewarding meetings with potential customers that the company will follow up on. The recorded presentation can be found here .

Stayble publishes prospectus in connection with the forthcoming rights issue

Stayble Therapeutics AB (”Stayble” or the ”Company”) hereby publishes prospectus in connection with the Company’s forthcoming rights issue, with a subscription period that begins Wednesday, 3 February 2021. The prospectus has today been approved and registered by the Swedish Financial Supervisory Authority and will be available on their website (www.fi.se). The prospectus is also available on the websites of the Company (www.staybletherapeutics.se), Sedermera Fondkommission (www.sedermera.se) and Nordic Issuing (www.nordic-issuing.se). Teaser and subscription forms will be published on the

AKER ASA: Aker Horizons – Contemplated private placement and convertible bond issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. Reference is made to the previous stock exchange announcement made by Aker ASA ("Aker") on 19 January 2021 regarding the acquisition of Mainstream Renewable Power (the “Acquisition”), a private placement (the “Private Placement”) and a listing on Euronext Growth Oslo (the “Listing”, and together with the Private Placement, the "IPO") of Aker

#21-34 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#21-33 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Ovzon receives ISO 9001 certification

Ovzon has received ISO 9001 for its quality management system. With a formalized quality management system in place, Ovzon is well positioned to serve customers in both the defence and commercial markets.“The ISO 9001 certification highlights Ovzon’s commitment to deliver quality services and products to the industries we serve. With our certified quality management system in place and our recently presented Ovzon T6 terminal and the launch of our first own satellite, Ovzon 3, we are well positioned to serve our customer’s needs and to meet and exceed their expectations”,says Magnus René,

Sveaskog’s Year-end Report January-December 2020: Lower Profits due to Lower Prices

Sveaskog reports an operating profit of MSEK 1,120 (1,483) for 2020, which is 24 per cent lower than in the same period in the previous year. A fall in profit was expected, as the prices of our products declined gradually in 2019, and the trend has continued into 2020.[Vintertrd] January – December 2020 · Net sales decreased by eight per cent to MSEK 6,597 (7,209). Prices of wood raw materials were down by nine per cent on average while total delivery volumes declined one per cent. · Operating profit decreased by 24 per cent to MSEK 1,120 (1,483). The decrease in profit can be

Arriver™ presents software stack for Advanced Driver Assistance and semi-autonomous driving

Stockholm, Sweden, January 27, 2021: Arriver™ today presents the capabilities of its next generation software stack for Advanced Driver Assistance and (ADAS) and semi-autonomous driving. The presentation by Arriver’s Head of Technology, Salah Hadi at Qualcomm’s annual Automotive Summit outlines how Arriver™ will provide a leading software stack enabling Level 1 ADAS to Level 3 semi-autonomous driving in 2024.Arriver™ is developing this next generation software stack to be an open, flexible and scalable solution which will allow automotive manufacturers and automotive suppliers to, based on

OPINION: Targeting climate positive by 2030 and transitioning to Net Zero: A new framework for business action

Håkan Nordkvist, Innovation & Development Manager at Ingka Group shares his views on contributing to a world leading study by the University of Cambridge looking at a net zero roadmap to support businesses to take action on climate change.Climate change is the biggest threat that the planet faces. As a large retailer, IKEA is committed to tackling climate change and ensuring we meet the rapidly evolving needs of customers, co-workers, and the planet is a key priority. At IKEA we want to become circular and climate positive by 2030 while growing the IKEA business 

Read original

SpareBank 1 SR-Bank ASA (SRBNK): Invitation to the presentation of fourth quarter 2020 accounts, Thursday, 11 February

SpareBank 1 SR-Bank's fourth quarter 2020 accounts will be released at 7.30 am on Thursday 11 February, and we would like to invite you to the following presentations; 8:15 am CET - Presentation in Norwegian, live web-TV broadcastThe presentation will be made by CEO Benedicte Schilbred Fasmer and CFO Inge Reinertsen. A broadcast will be available on the Investor Relations pages at www.sr-bank.no/ir1:30 pm CET - Conference call for analysts and investorsThe presentation will be made by CEO Benedicte Schilbred Fasmer and CFO Inge Reinertsen in English. From Norway: Call 21 40 21

Invitation to LeadDesk’s January–December 2020 results briefing

LeadDesk Plc Press Release 27 January 2021 16.00 EETLeadDesk will publish their 2020 financial statements bulletin on Thursday, 18 February 2021 at 10.00 EET. The company is organising a results briefing for analysts, the media and investors on 18 February 2021 at 12.00 EET. The briefing will be held as a Microsoft Teams webcast.LeadDesk CEO Olli Nokso-Koivisto will host the briefing and present the financial statement as well as forecasts for 2021. The event will be held in English. LeadDesk kindly asks interested parties to register for the briefing by emailing CFO Pauliina Leimu

In 2021, spices give everyone a way to travel the world – the quality and origin of pepper attract increasing interest

“One of this year’s food trends is to explore flavours from all parts of the world in the home kitchen,” says Magdalena Färemo, Paulig’s Knowledge & Insight Director. Diversity is the key trend in the use of black pepper. Consumers also want to know about sustainability issues and origin. According to Paulig’s sustainability promise, by 2023, all Paulig Santa Maria pepper will come from sources verified by a third party. The exceptional amount of time spent at home has made people try new flavours and enhance cooking skills. “On the other hand, people are also interested in quick

G5 Entertainment releases new puzzle game Empire Blast in Russia

G5 Entertainment announces the release of its new free-to-play puzzle game, Empire Blast, currently only available in the Apple App Store and limited to Russia. “With Empire Blast, G5 further expands its audience to those preferring the Blast mechanic, which has been gaining popularity. Blast is a new game mechanic for the company. Depending on the results of this soft-launch, we can quickly form a larger offering of games for this particular part of the market,” said Vlad Suglobov, CEO of G5 Entertainment. In this new puzzle game, players travel back to Cabrera, a remote settlement

BioStock: CombiGene headhunts again

With experience from Medical Affairs at MERCK and early drug development at Karo Bio, a solid background in research from a doctoral thesis at Karolinska Institutet and postdoctoral research at Mount Sinai School of Medicine in New York, Pernilla Fagergren chose to join the Swedish gene therapy company CombiGene. In her new role as Clinical Project Manager, she will be responsible for the company’s first clinical study in epilepsy. Pernilla talks to BioStock about the challenges, before the Phase I study can begin next year.Read the full interview with Pernilla Fagergren at  biostock.se:

New Business Update - Ayima Group AB

Further to the previous update from December 4, 2020, Ayima is pleased to inform the market of its continued success in growing the business.  The 4th Quarter of 2020 was the company's best period of sales performance to date, and despite the delays caused by the Christmas and New Year period, 2021 has begun well, with 10 new client contracts signed, to a total value of approxiately 2.4 MSEK in the initial contracted period. Ayima's standard terms are 12 months, with an automatic renewal, however several of the contracts signed this month are for short initial trial periods and are

Nanologica Signs Collaboration Agreement with Zentiva for the use of NLAB Drug Delivery Platforms

A collaboration agreement for the use of the NLAB drug delivery platforms has been signed with Zentiva, a pharmaceutical company operating in Europe and beyond. The aim of this collaboration agreement is to simplify the contract process for future product-specific agreements.The agreement gives Zentiva the right to use the NLAB drug delivery platforms for multiple drug development projects. Project specific agreements will be signed separately under this collaboration agreement. ” We first met Zentiva during BIO-Europe in 2019. Since then, we have had a continuous dialogue as they see

There are no items matching the current filter
There are no more items matching the current filter
Back to top